Icosavax (NASDAQ:ICVX) Announces Earnings Results

Icosavax (NASDAQ:ICVX) released its earnings results on Monday. The company reported ($2.86) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.90) by ($1.96), MarketWatch Earnings reports.

Shares of ICVX opened at $37.75 on Tuesday. Icosavax has a 52 week low of $21.70 and a 52 week high of $49.99.

A number of research analysts have weighed in on the stock. Cowen assumed coverage on shares of Icosavax in a research report on Monday, August 23rd. They set an “outperform” rating for the company. Jefferies Financial Group began coverage on shares of Icosavax in a research report on Monday, August 23rd. They set a “buy” rating and a $50.00 price objective for the company. Evercore ISI began coverage on shares of Icosavax in a research report on Monday, August 23rd. They set an “outperform” rating and a C$50.00 price objective for the company. Finally, William Blair began coverage on shares of Icosavax in a research report on Monday, August 23rd. They set an “outperform” rating and a $45.70 price objective for the company.

Icosavax Company Profile

Icosavax Inc is a biopharmaceutical company which focuses on life-threatening respiratory diseases. The company’s virus-like particle platform technology involved in developing vaccines against infectious diseases. Icosavax Inc is based in SEATTLE.

Read More: Technical Analysis

Receive News & Ratings for Icosavax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icosavax and related companies with MarketBeat.com's FREE daily email newsletter.